Sanofi signs pair of billion-dollar biotech deals to bolster pipeline
Sanofi has agreed $1.7bn and $1.04bn licensing deals with Dren Bio and ADEL, respectively.
deal
Biopharma’s 2025 M&A boom: Dealmaking surges as patent pressures intensify
Real-time data: how to gain an edge amid clinical services consolidation
Pfizer clinches $10bn Metsera deal as Novo Nordisk retreats
Novo Nordisk locks horns with Pfizer in late bid for Metsera
Bavarian Nordic’s shareholders and board in standoff amid takeover offer
BioCryst to buy Astria Therapeutics for $700m in enterprise value
Roche signs agreement to acquire 89bio in $2.4bn deal
